EU Launches Joint Scientific Consultations to E...

By João L. Carapinha

January 14, 2026

Launching Joint Scientific Consultations in 2026 The European Commission has initiated the first submission period for Joint Scientific Consultations under the EU Health Technology As...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation
Driving Economic Transformation through Brain Health Investment in Africa
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...
Weight Loss: Advances in Hormone-Based Obesity Treatments
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...